Stock listing
NASDAQ:AVXS AveXis Inc Stock
Follow AveXis Inc into a list and get an email when it puts out news.
Last close · NASDAQ:AVXS
$217.83 USD
Close on May 15, 2018 · No longer trades
- Lowest – highest close
- $17.80 – $217.83 USDSince Feb 11, 2016 · lowest Feb 12, 2016 · highest May 14, 2018
Delisted NASDAQ:AVXS no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:AVXS
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
AveXis Inc on 6ix
- Decks
- 7 decks · latest Feb 27, 2018
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (February 2018) | Investor deck | 15 slides | Feb 27, 2018 |
| Corporate Update (April 2017) | Corporate update | 23 slides | Apr 25, 2017 |
| FY2016 Earnings Presentation | Earnings | 18 slides | Mar 16, 2017 |
| Investor Presentation (January 2017) | Investor deck | 21 slides | Jan 9, 2017 |
| Corporate Update (October 2016) | Corporate update | 21 slides | Oct 11, 2016 |
| Q2 2016 Earnings Presentation | Earnings | 16 slides | Aug 11, 2016 |
| Technical Presentation (May 2016) | Technical | 21 slides | May 6, 2016 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| James Flynn Other companies: Lite Strategy, Inc. (Non-Executive Director · Since at least Oct 31, 2023); Nuvalent, Inc. (Director · Since at least Jul 28, 2021); Larimar Therapeutics, Inc. (Director · Since at least May 28, 2020); Synlogic Inc (Director · Mar 19, 2024 – Apr 26, 2025 · Past); BiomX Inc. (Director · Mar 15, 2024 – Apr 21, 2025 · Past); Oruka Therapeutics, Inc. (Director · Jan 30, 2024 – Jan 30, 2024 · Past); RiceBran Technologies (Director · Jan 3, 2024 – Jan 3, 2024 · Past); CareMax Inc (Director · Nov 17, 2022 – Nov 17, 2023 · Past); ARS Pharmaceuticals, Inc. (Director · Nov 8, 2022 – Nov 8, 2022 · Past); Da32 Life Science Tech Acquisition Corp (Director · Jul 27, 2021 – Jul 28, 2023 · Past); Oncorus Inc (Director · Oct 1, 2020 – Feb 17, 2021 · Past); Acutus Medical Inc. (Director · Aug 5, 2020 – Jan 27, 2025 · Past); Deerfield Healthcare Technology Acquisitions Corp (Director · Jul 16, 2020 – Jul 21, 2020 · Past); Q32 Bio Inc. (Director · Mar 27, 2018 – Jun 6, 2019 · Past); AdaptHealth Corp. (Director · Feb 15, 2018 – Nov 8, 2019 · Past); Alpine Immune Sciences Inc (Director · Sep 12, 2016 – Sep 12, 2016 · Past) | Director · Sep 3, 2015 – Feb 10, 2016 · Past |
| Daniel G. Welch Other companies: Prothena Corporation plc (Chair of the Board · Since at least Feb 21, 2024); Structure Therapeutics, Inc. (Director · Since at least Feb 2, 2023); Ultragenyx Pharmaceutical Inc. (Director · Since at least Apr 8, 2015); Nuvation Bio Inc. (Director · Feb 10, 2021 – May 24, 2024 · Past); Intercept Pharmaceuticals Inc (Director · Nov 24, 2015 – May 28, 2020 · Past); Corium International Inc (Director · Apr 2, 2014 – Apr 2, 2014 · Past); Hyperion Therapeutics Inc (Director · Aug 23, 2012 – May 7, 2015 · Past); Seagen Inc (Director · Jun 13, 2007 – Dec 14, 2023 · Past); InterMune Inc (Chairman, CEO and President, Director · Mar 15, 2006 – Sep 29, 2014 · Past) | Director · Feb 10, 2016 – May 15, 2018 · Past |
| Jonathan Leff Other companies: Larimar Therapeutics, Inc. (Director · Since at least May 28, 2020); BiomX Inc. (Director · Mar 15, 2024 – Apr 14, 2025 · Past); ARS Pharmaceuticals, Inc. (Director · Nov 8, 2022 – Nov 8, 2022 · Past); Protara Therapeutics, Inc. (Director · Aug 2, 2017 – Jun 8, 2018 · Past); Alpine Immune Sciences Inc (Director · Jun 16, 2015 – Sep 11, 2015 · Past); InterMune Inc (EVP, Research & Development · Feb 27, 2012 – Sep 29, 2014 · Past) | Director · Feb 10, 2016 – Feb 10, 2016 · Past |
| Phillip Donenberg Other companies: Sensei Biotherapeutics, Inc. (Chair of the Audit Committee · Since at least Feb 13, 2026); Taysha Gene Therapies, Inc. (Director · Since at least Sep 23, 2020); Tectonic Therapeutic, Inc. (Director · Since at least Jun 20, 2018); Depomed Inc (SVP and CFO · Jul 16, 2018 – Jul 16, 2018 · Past); CervoMed Inc. (Director · May 27, 2014 – Jul 24, 2014 · Past); ANI Pharmaceuticals, Inc. (Sr VP of Finance, CFO, Secy · Mar 16, 2006 – Jan 25, 2012 · Past) | Chief Financial Officer · Oct 19, 2017 – May 15, 2018 · Past |
| Sukumar Nagendran Other companies: Taysha Gene Therapies, Inc. (Director · Since at least Sep 23, 2020); Solid Biosciences Inc. (President, Head of Research & Development, Taysha Gene Therapies · Since at least Sep 12, 2018); Immunovant, Inc. (Director · May 9, 2019 – May 9, 2019 · Past) | Sr. VP & Chief Medical Officer · Feb 10, 2016 – May 15, 2018 · Past |
| Rick Modi Other companies: Astria Therapeutics Inc (Chief Business Officer · Jun 24, 2015 – Sep 8, 2016 · Past) | Chief Business Officer · Feb 13, 2017 – May 15, 2018 · Past |
| Bong Y Koh | Director · Feb 10, 2016 – May 15, 2018 · Past |
| James J Litalien | SrVP/Chief Reg&Quality Officer · Feb 10, 2016 – May 15, 2018 · Past |
| Lori J Smith | SVP-Chief Human Resource Off. · Mar 13, 2018 – May 15, 2018 · Past |
Log in to ask 6ix AI your own questions about AveXis Inc.